{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22507593",
  "DateCompleted": {
    "Year": "2012",
    "Month": "09",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "03",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "04",
        "Day": "07"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.drudis.2012.03.018"
    ],
    "Journal": {
      "ISSN": "1878-5832",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "9-10",
        "PubDate": {
          "Year": "2012",
          "Month": "May"
        }
      },
      "Title": "Drug discovery today",
      "ISOAbbreviation": "Drug Discov Today"
    },
    "ArticleTitle": "Can we vaccinate against depression?",
    "Pagination": {
      "StartPage": "451",
      "EndPage": "458",
      "MedlinePgn": "451-8"
    },
    "Abstract": {
      "AbstractText": [
        "Major depression is common in the context of autoimmune and inflammatory diseases and is frequently associated with persistently raised levels of proinflammatory cytokines and other markers of inflammation, even in the absence of another diagnosable immune pathology to account for these findings. Therefore immunoregulation-inducing vaccines or manipulations of the gut microbiota might prevent or treat depression. These strategies are already undergoing clinical trials for chronic inflammatory disorders, such as allergies, autoimmunity and inflammatory bowel disease. In this article, we summarize data suggesting that this approach might be effective in depression and encourage the initiation of clinical vaccination trials in this disorder."
      ],
      "CopyrightInformation": "Copyright \u00a9 2012. Published by Elsevier Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Clinical Microbiology, Department of Infection, University College London (UCL), London NW3 2PF, UK."
          }
        ],
        "LastName": "Rook",
        "ForeName": "Graham A W",
        "Initials": "GA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Raison",
        "ForeName": "Charles L",
        "Initials": "CL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lowry",
        "ForeName": "Christopher A",
        "Initials": "CA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Drug Discov Today",
    "NlmUniqueID": "9604391",
    "ISSNLinking": "1359-6446"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Expert Opin Biol Ther. 2017 May;17 (5):525-528",
      "PMID": "28277809"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [
        "immunology",
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "immunology",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Intestines"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Vaccines"
    }
  ]
}